Cornea and External Disease



Cornea and External Disease


Deborah Pavan-Langston

Kathryn Colby



I. Normal anatomy and physiology



  • Conjunctiva: Anatomy



    • Gross anatomy. The conjunctiva is a thin, transparent mucous membrane lining the inner surface of the eyelid (palpebral conjunctiva) and covering the anterior sclera (bulbar conjunctiva). The palpebral portion is designated as marginal, tarsal, and orbital and merges with the conjunctiva of the superior and inferior fornices in loose folds. The bulbar conjunctiva is adherent to the underlying Tenon capsule and therefore to sclera, with the tightest adhesion occurring in a narrow band at the corneoscleral limbus. A delicate vertical crescent, the semilunar fold (plica semilunaris), separates the bulbar conjunctiva from the lacrimal caruncle at the medial canthus. The conjunctiva tends to be a mobile tissue and is capable of great distention with edema fluid, as is often seen with trauma or inflammation.


    • Microscopically, the conjunctiva is composed of (a) an anterior stratified columnar epithelium that is continuous with the corneal epithelium, and (b) a lamina propria composed of adenoid and fibrous layers. The epithelium is from two to seven layers thick and contains numerous unicellular mucous glands (goblet cells) that secrete the inner mucoid layer of the tear film. Although the healthy epithelium is never keratinized, it may become keratinized in certain disease states. The lamina propria is composed of connective tissue housing blood vessels, nerves, and glands. The accessory lacrimal glands of Krause are located deep in the substantia propria in the superior and inferior fornices. The accessory lacrimal glands of Wolfring are situated near the upper margin of the superior tarsal plate. The adenoid layer of the lamina propria, which develops particularly after 3 months of age, contains lymphocytes enmeshed in a fine reticular network without the presence of true lymphoid follicles. The fibrous layer of the lamina propria surrounds the smooth palpebral muscle of Müller.


    • The blood supply of the palpebral conjunctiva originates from peripheral (bulbar and fornix) and marginal arterial arcades of the eyelid. Within 4 mm of the limbus, the vascular supply is derived from the anterior conjunctival branches of the anterior ciliary arteries (superficial plexus), which anastomose with the posterior conjunctival vessels from the peripheral arcade. Conjunctival vessels move with the conjunctiva and constrict with instillation of 1:1,000 epinephrine—a point of differentiation from the deeper episcleral and ciliary vessels.


    • Innervation of the bulbar conjunctiva is via the sensory and sympathetic nerves from the ciliary nerves. The remaining palpebral and fornix conjunctiva is innervated by the ophthalmic and maxillary divisions of the trigeminal nerve (cranial nerve V).


    • Lymphatic drainage of the conjunctiva parallels that of the lid, with lateral drainage to the preauricular nodes and medial drainage to the submandibular nodes.


  • Cornea



    • Gross anatomy. The cornea represents the anterior 1.3 cm2 of the globe and is the main refracting surface of the eye. Although the cornea is continuous with the sclera at the limbus, the anterior corneal curvature (radius equal to 7.8 mm) is greater than that of the sclera, with the central 4-mm optical zone almost
      spherical and the periphery gradually flattening toward the scleral curve. The horizontal diameter of the anterior surface of the cornea (11.6 mm) is longer than the vertical diameter (10.6 mm), so that the anterior aspect of the cornea forms a horizontal ovoid. Viewed from the posterior surface, the cornea is circular (with a diameter of 11.6 mm). A corneal diameter greater than 12.5 mm is termed megalocornea; a corneal diameter less than 11 mm is termed microcornea. The height of the cornea from the basal plane of the visible limbus to the apex is 2.7 mm. The central thickness of the cornea is 0.52 mm, which increases to 0.7 mm in the far periphery.


    • Microscopically, the cornea consists of five strata: the epithelium and its basement membrane, Bowman layer, stroma, Descemet membrane, and endothelium.



      • The corneal epithelium is a uniform five- to six-layer structure 50 μm to 100 μm thick and composed of (a) a basal cell layer of replicating cylindric cells, 18 μm high and 10 μm wide, (b) a wing cell layer with superior convex–inferior scalloped cells interdigitating between the apices of the basal cells, and (c) surface cells composed of flat cells in two or three layers culminating in a smooth corneal surface that is studded with ultrastructural microplicae and microvilli. Corneal nerves passing from the corneal stroma through Bowman layer terminate freely between the epithelial cells, thus accounting for the great sensitivity of the cornea. The epithelium is firmly attached to the underlying Bowman layer by a continuous basement membrane that is a very important source of firm epithelial adhesion.


      • The Bowman layer is a homogeneous condensation of the anterior stromal lamellae continuous with the corneal stroma. Its termination at the corneal periphery marks the anterior margin of the corneoscleral limbus.


      • The stroma represents 90% of the corneal thickness, with bundles of collagen fibrils of uniform thickness enmeshed in mucopolysaccharide ground substance. These bundles form 200 lamellae arranged parallel to the corneal surface but with alternate layers crisscrossing at right angles. This regular lattice structure, coupled with the deturgescent state of the stroma, has been credited with providing the extreme transparency of the cornea necessary for optical clarity.


      • The Descemet membrane is the basement membrane of the endothelial cells and can be easily stripped from the stroma. When torn or traumatized, the ends will tend to retract, indicating an inherent elasticity. Gradual thickening of this layer with age is noted, with the thickness approximately 3 μm to 4 μm at birth but increasing to 10 μm to 12 μm in adulthood. Peripheral dome-shaped excrescences of the Descemet membrane (Hassall-Henle warts) occur in persons older than 20 years. Histologically, the membrane is a homogeneous glasslike structure, but ultrastructurally, it is composed of stratified layers of very fine collagenous filaments in the anterior layer (anterior banded layer) with an amorphous posterior layer that increases with age.


      • The endothelium is a single layer of approximately 500,000 polygonal cells, 5 μm to 18 μm in size, which spread uniformly across the posterior surface of the cornea. The corneal endothelium maintains corneal deturgescence and contributes to the formation of the Descemet membrane. Corneal endothelial cells generally do not divide after birth and are arrested in the G1 phase of the cell cycle. These cells can be stimulated to divide in vitro using a combination of growth factors. Since the endothelium is post-miotic in the adult, cell loss (due to trauma or underlying corneal dystrophy) is compensated for by migration and enlargement of the remaining endothelial cells.


    • The blood supply of the cornea arises predominantly from the conjunctival, episcleral, and scleral vessels that arborize about the corneoscleral limbus. The cornea itself is avascular.


    • The innervation of the cornea is that of a rich sensory supply mostly via the ophthalmic division of the trigeminal nerve. This innervation is via the long ciliary nerves that branch in the outer choroid near the ora serrata region. These
      nerves pass via the sclera into the middle third of the cornea as 70 to 80 large nerve trunks that lose their myelin sheaths approximately 2 to 3 mm from the limbus but can be visualized as fine filaments beyond. There is significant dichotomous and trichotomous branching, and the subsequent passage of nerve fibers through the Bowman layer ends freely between the epithelial cells.


  • Physiology: Precorneal tear film



    • The physiology of the cornea and conjunctiva is best introduced in a discussion of the precorneal tear film. This film, which is 6 to 10 μm thick, is composed of three layers: (a) superficial lipid layer, (b) middle aqueous layer, and (c) inner mucous layer. The normal tear volume in the conjunctival sac is about 3 to 7 μL and can increase to the conjunctival sac capacity of 25 μL before overflow occurs. Tear flow rate is approximately 1 μL per minute and comes from the secretion of the main and accessory lacrimal glands. After their release in the superotemporal region, the tears are distributed by the blinking action of the lids, with the tear meniscus forming superior and inferior marginal tear strips before draining into the lacrimal puncta located near the medial canthus. With a pH of 7.6 and an osmolarity comparable to sodium chloride 0.9%, there is a low glucose concentration and an electrolyte distribution similar to plasma, with the exception of a slightly greater potassium content. Oxygen dissolves readily in the tear film, and the dissolved protein content of the tear film includes immunoglobulins and lysozyme. These characteristics allow the tear film to provide a smooth surface for refraction, to mechanically wash and protect the cornea and conjunctiva, to provide oxygen exchange for the epithelium, to lubricate the surface during a blink, and to provide bacteriostasis. Tear film homeostasis requires an intact “lacrimal function unit,” which is a feedback loop involving cranial nerves V (sensory) and VII (motor), the lacrimal apparatus, and integrative structures within the central nervous system. Perturbation of any of these components can interfere with the proper composition and function of the tear film.


    • Corneal function. The primary physiologic function of the cornea is to maintain an optically smooth surface and a transparent medium while protecting the intraocular contents of the eye. This duty is fulfilled by the effective interaction of the epithelium, stroma, and endothelium. The epithelium, endothelium, and Descemet membrane are transparent because of the uniformity of their refractive indices. The transparency of the stroma is conferred by the special physical arrangement of the component fibrils. Although the refractive index of collagen fibrils differs from that of the interfibrillar substance, the small diameter of the fibril (300 Å) and the small distance between them (300 Å) provide a separation and regularity that causes little scattering of light despite the optical inhomogeneity. The relative state of deturgescence is provided by the barrier functions of the epithelium and endothelium, as well as by the dehydrating function of the endothelium. Disturbance of this equilibrium, such as occurs in corneal edema, will increase light scattering and the opacity of the stroma.



      • The anterior epithelial surface, with its microplicae and microvilli, provides the scaffold for a smooth and continuous precorneal tear film. In addition, the epithelium serves as a relatively impermeable barrier to water-soluble materials. The epithelium also provides an effective barrier to many infectious agents. The epithelium is the most mitotically active layer of the cornea and, because of its high cellular density, consumes considerable glucose and oxygen. The major source of oxygen for the epithelium is atmospheric oxygen dissolved in the tear film, which explains the sensitivity to hypoxia that occurs with improperly fitted or overworn contact lenses. Glucose for the epithelium is obtained from the aqueous humor by diffusion through the corneal stroma. The substance is either used or stored as glycogen. Epithelial metabolism occurs through the hexose monophosphate shunt or tricarboxylic acid cycle in the presence of oxygen, or via the anaerobic glycolysis pathway in the absence of oxygen. With these metabolic capabilities, the turnover of the epithelium is rapid, occurring approximately
        once every 7 days, and explains the ability of the epithelium to heal itself rapidly.


      • Stroma. There is little turnover of the stromal matrix, and the keratocytes may survive as long as 2 years under normal conditions. Glucose is obtained from the aqueous humor and oxidized via the Embden-Meyerhof tricarboxylic acid cycle. Interaction of the interfibrillar substances, particularly the acid mucopolysaccharides, generates a swelling pressure for the stroma both in vivo and in vitro. This tendency to imbibe fluid results in light scattering if it is not kept in check by the dehydrating function of the endothelium.


      • Endothelium. The major function of the endothelium is the maintenance of proper corneal hydration. The endothelium requires oxygen and glucose to maintain the metabolically active process, but the exact nature of the endothelial pump is not completely clear. Impairment of the pump function can occur in dystrophic conditions (Fuchs dystrophy), injury (postsurgical or traumatic), and in some inflammatory conditions (anterior segment necrosis).


II. Acute traumatic conditions



  • Abrasions and lacerations (see Chapter 2)


  • Perforations



    • Etiologically, corneal perforation can result from any corneal ulceration, either infectious (bacterial, fungal, or viral), inflammatory (rheumatoid arthritis or collagen disease), posttraumatic (burn), or trophic defects of degenerations, neurotrophic ulcer, or postherpetic ulcer. Use of topical nonsteroidal anti-inflammatory drugs (NSAIDs) such as diclofenac in at-risk patients may trigger or worsen thinning and perforation.


    • Treatment. Occasionally, these perforations will seal with a small knuckle of iris and rarely can be self-sealing, but they usually result in partial or complete loss of the anterior chamber. Thus, in most cases, they represent an urgent situation to be treated. Small, noninfectious perforations can often be splinted by use of a therapeutic soft contact bandage lens (Permalens, Kontur). Such treatment will sometimes allow healing of the perforation but often is a stabilizing or interim treatment that requires further definitive therapy. Medical adhesive is of great use in helping to seal small perforations. Cyanoacrylate tissue adhesive (Dermabond Ethicon; not U.S. Food and Drug Administration [FDA] approved for ocular use) can successfully seal a perforation without excess ocular toxicity. It is essential that epithelium and necrotic stroma be débrided to allow firm adhesion of the cyanoacrylate glue to surrounding healthy basement membrane. A thin application of this glue will often remain intact for several months and is tolerated by the patient if covered with a continuously worn soft contact lens (Plano T). Healing of the corneal defect will often occur beneath the glue. Even if spontaneous healing of the leak is not expected, the glue will provide adequate time to obtain corneal donor material if keratoplasty becomes necessary. It is essential to observe the patient closely to ensure that the anterior chamber has reformed and that there is no associated superinfection. Topical antibiotic coverage is advisable after gluing and with the use of a soft contact lens. When contact lens or adhesive therapy is inadequate, surgical patch grafting will usually be successful. For moderate-size perforations, a small lamellar button may be sutured into the débrided defect. In the event of large central perforations, it may be preferable to perform penetrating keratoplasty.


  • Burns. Anterior segment burns may be chemical, thermal, radiation, or electric (see Chapter 2).


  • Subconjunctival hemorrhage may be induced with major, minor, or no detectable trauma to the front of the eye. Occasionally, a patient will wake up with a “spontaneous” hemorrhage. Clinically, it presents as a striking flat, deep-red hemorrhage under the conjunctiva and may become sufficiently severe to cause a dramatic chemotic “bag of blood” to protrude over the lid margin. Occasionally, pneumococcal or adenoviral conjunctivitis may be associated, in which case there will be
    discomfort and discharge. In the absence of infection or significant trauma to the eye, treatment is unnecessary. The patient should be reassured that the blood will clear over a 2- or 3-week period.


III. Lid and conjunctival infection and inflammation



  • Blepharitis and conjunctivitis can be acute or chronic, infectious or inflammatory.



    • Acute blepharitis often overlaps with meibomian gland dysfunction. Staphylococcus aureus is the most common cause of infection, but other species may be at fault. It is characterized by tender lid edema; erythema; lash loss; hard, anterior lid location of fibrinous crusts and scales; and occasional lid ulceration, tear instability, corneal punctate keratitis, infiltrates, vascularization, and phylctenulosis.


    • Chronic bacterial blepharoconjunctivitis, rosacea, and meibomian gland dysfunction (MGD)



      • S. aureus is the most common cause of chronic bacterial conjunctivitis or blepharoconjunctivitis, with S. epidermidis, Propionibacterium acnes, Corynebacterium sp, and the yeast Pityrosporium being other etiologic agents. Often this conjunctivitis is associated with ocular rosacea or rosacea of the skin, and MGD. Rosacea, a cutaneous vascular, acneiform disorder with four forms (erythematotelangiectasia, papulopustular, phymatous, and Ocular), presents with facial flushing, telangiectatic vessels, papules and pustules, and occasional sebaceous gland hyperplasia of the nose (rhinophyma). More than 50% of patients will have ocular changes that include dryness and irritation, burning, stinging, low tear production, MGD with telangiectasia, hordeola + chalazia (see Chapter 3), chronic conjunctivitis, marginal corneal infiltrates or scarring, and episcleritis. MGD, another infrequently recognized cause of ocular irritation, may be “obstructive,” found with anterior blepharitis, or “nonobstructive,” posterior blepharitis. Anterior blepharitis (seborrheic) has oily crusts on the lashes and lids; red, thickened lids anterior to the grey line; expressible turbid oil in the glands; aqueous tear deficiency (30%); punctate keratitis (15%); and often oily crusting of the brows and scalp. Posterior blepharitis is hypersecretory meibomian seborrhea with inspissated oil glands, fluorescein staining along the palpebral conjunctival margin, notable telangiectatic blood vessels, foam, hordeola, stys, and often rapid tear breakup time. There is often colonization of the meibomian orifices and lash follicles with Staphylococcus. If there is associated Staphylococcus, it can produce a variety of exotoxins. An ulcerative blepharitis can occur, as well as an eczematoid scaling and sometimes weeping inflammation.


      • Eczema blepharitis, scaly crusts on a red base, is usually distinguishable from the less severe, oily seborrheic blepharitis. There is often colonization of the meibomian orifices and lash follicles with Staphylococcus. An angular blepharoconjunctivitis with maceration of the tissue at the lateral canthus, at one time most commonly associated with Moraxella sp, is now most commonly produced by Staphylococcus. The cornea also can be involved, with an inferior superficial punctate keratitis or by limbal infiltrates. Marginal corneal ulcers can be produced by chronic staphylococcal blepharoconjunctivitis (see Section IV.B.2).


      • Other causes of chronic blepharitis are the mite Demodex and lice. The former obligate parasites inhabit hair follicles and sebaceous glands and appear as waxy sleeves around lashes or cylinders protruding from sebaceous glands. Treatment is lid hygiene. Lice infestations (phthiriasis palpebrum) are caused by the pubic louse and may be treated by smothering them with any eye ointment bid for at least 10 days. The pubic area is treated with a pediculocide.


    • Acute and chronic bacterial conjunctivitis. Conjunctivitis is an inflammation of the conjunctiva characterized by vascular dilation, cellular infiltration,
      and exudation. The differential features of bacterial conjunctivitis versus those caused by virus, allergy, or toxic factors are listed in Table 5.1.








      TABLE 5.1 Clinical Features of Conjunctivitis
























































































      Sign Bacterial Viral Allergic Toxic TRIC
      Injection Marked Moderate Mild/Moderate Mild/Moderate Moderate
      Hemorrhage + +
      Chemosis ++ +/- ++ +/- +/-
      Exudate Purulent Scant/watery Stringy/white Scant
        Mucopurulent        
      Pseudomembrane +/- Streptococcus +/-
        Corynebacterium        
      Papillae +/- +
      Follicles + +
      (Medication)
      +
      Preauricular node + ++ +/-
      Pannus
      (Except vernal)
      +
      TRIC, trachoma-inclusion conjunctivitis; ++, strongly positive; +, positive; +/-, sometimes positive; -, negative.

      The acute stage of conjunctivitis is classically recognized by vascular engorgement and mucopurulent discharge, with the associated symptoms of irritation, foreign body sensation, and sticking together of the lids. Occasionally, a severe reaction with purulent conjunctivitis and corneal involvement can occur. The chronic conjunctival infection is more innocuous in its onset, runs a protracted course, and is often associated with involvement of the lids or lacrimal system by low-grade inflammatory reaction. A wide variety of bacterial organisms can infect the conjunctiva. Although the bacterial etiology is often clinically apparent, the identity of the causative organism may not be obvious. Certain clinical features determined by the pathogenicity of the infectious agent, however, may provide an accurate clinical diagnosis.



      • Staphylococcus aureus is probably the single most common cause of bacterial conjunctivitis and blepharoconjunctivitis in the Western world. The aerobic Gram-positive coccus is often harbored elsewhere on the skin or in the nares. It may affect any age group. Although usually not aggressively invasive, the organism is very toxigenic and can provide corneal infiltrates, eczematous blepharitis, phlyctenular keratitis, and angular blepharitis.


      • Staphylococcus epidermidis is usually considered an innocuous inhabitant of the lids and conjunctiva, but in some instances it can cause blepharoconjunctivitis. The organism is capable of producing necrotic exotoxin and has been shown to colonize eye cosmetics, with subsequent production of blepharoconjunctivitis.


      • Streptococcus pneumoniae (pneumococcus) is an aerobic encapsulated Gram-positive diplococcus that is often present in the respiratory tracts of asymptomatic carriers. This organism more commonly affects the conjunctiva of children and can run a self-limiting course of 9 to 10 days.


      • Streptococcus pyogenes is an aerobic Gram-positive coccus. Although an infrequent cause of conjunctivitis, the organism is invasive and toxigenic, and thus is capable of producing a pseudomembranous conjunctivitis. The pseudomembrane consists of a fibrinous layer entrapping inflammatory cells and is attached to the conjunctival surface. Removal of this pseudomembrane is possible with minimal bleeding of the underlying tissue.



      • Haemophilus influenzae (H. aegyptius, Koch-Weeks bacillus) is a fastidious aerobic Gram-negative pleomorphic organism often seen as a slender rod or a coccobacillary form. It is frequently isolated from upper respiratory tracts of healthy carriers and most commonly causes conjunctivitis in children rather than in adults. It is a toxigenic organism and can be accompanied by patchy conjunctival hemorrhages during an acute infection. An untreated case can last for 9 to 12 days, occurring as a self-limited infection, but occasionally can be part of a more ominous periorbital cellulitis associated with respiratory infection that can lead to bacteremia in young children. Accompanying the acute infection and probably a manifestation of the toxigenic potential is the presence of inferior corneal limbal infiltrates.


      • Moraxella lacunata is an aerobic Gram-negative diplobacillus once considered the most common cause of angular blepharoconjunctivitis. Although angular blepharoconjunctivitis is now more commonly the result of staphylococcal infection, Moraxella sp can produce an acute conjunctivitis that occasionally results in a chronic conjunctivitis with follicular reaction.


    • Hyperacute conjunctivitis (acute purulent conjunctivitis)



      • Neisseria sp (gonococcus, meningococcus) are Gram-negative diplococci. Like Haemophilus sp, Streptococcus sp, and Corynebacterium diphtheriae, they are aggressively invasive bacteria that can produce a severe, often bilateral conjunctivitis. Occurring in the child as an infection from the maternal genital tract, in adolescents via fomite transmission, or in via inoculation from infected genitalia, the conjunctivitis can start as a routine mucopurulent conjunctivitis that rapidly evolves into a severe inflammation with copious exudate and marked chemosis and lid edema. This clinical appearance demands laboratory confirmation, immediate therapy, and occasionally hospitalization.


      • Neonatal conjunctivitis (ophthalmia neonatorum). Conjunctivitis of the newborn deserves special mention because of the severity and threatening potential of this condition. Conjunctivitis caused by Neisseria sp usually becomes symptomatic in the newborn 2 to 4 days following inoculation of the conjunctival mucosa at the time of birth. Clinically, a yellow purulent discharge with prominent lid edema and conjunctival chemosis appears. This condition needs to be distinguished from the neonatal conjunctivitis caused by inclusion conjunctivitis agents, chemical keratoconjunctivitis, nasolacrimal obstruction with other bacterial superinfection, or trauma. The differential points in diagnosis are listed in Table 5.2 (see Sections III.C.2 and Chapter 11).


      • Chronic conjunctivitis can also be produced by Gram-negative rods including Proteus mirabilis, Klebsiella pneumoniae, Serratia marcescens, and Escherichia coli. Gram-negative diplobacilli (M. lacunata) can produce a
        chronic blepharoconjunctivitis (angular conjunctivitis), as previously mentioned, and may be present with a chronic follicular reaction. The giant fornix syndrome is a little recognized cause of chronic, relapsing, grossly purulent conjunctivitis in the elderly. There is an unusually large upper conjunctival fornix, which houses copious amounts of purulent debris and usually S. aureus. Treatment is cipro- or ofloxacin 6 to 8 times per day, with prednisolone 1% or rimexolone bid to tid. Recurrences may be prevented by a single steroid-antibiotic drop daily. A noninfectious cause of chronic conjunctivitis and irritation is floppy eyelid syndrome, a condition seen most often in obese patients with sleep apnea. The loose, lax upper tarsus everts easily to expose tarsal conjunctiva and eye during sleep to cause papillary conjunctivitis and red eye. Treatment is bedtime lid taping shut, an eye shield, or horizontal lid shortening.








        TABLE 5.2 Neonatal Conjunctivitis





























        Agent Onset Cytology Culture
        Neisseria 2 d to 4 d Gram-negative intracellular diplococci Blood + chocolate agar (37°C, 10% CO2)
        Other bacteria 1 d to 30 d Gram-positive or Gram-negative organisms Blood agar
        Inclusion blenorrhea (TRIC) 2 d to 14 d Giemsa-positive intracytoplasmic inclusions Negative
        Chemical 1 d to 2 d Negative Negative or normal flora
        TRIC, trachoma-inclusion conjunctivitis.


      • Parinaud ocular glandular syndrome (catscratch disease, bartonellosis) is a febrile illness caused by the bacillus Bartonella henselae and is usually contracted through cat or flea exposure. Eye findings include unilateral conjunctival redness, often with epithelial ulceration, foreign body sensation, epiphora, mild lid swelling, serous to purulent discharge, and the disease hallmark, regional lymphadenopathy. Neuroretinitis and focal chorioretinitis are not uncommon (2%) (see Section III.D.4). Diagnosis is most cost-effective using serology, fluorescein antibody, or enzyme immunoassay.


  • Laboratory diagnosis in bacterial conjunctivitis is not routine. However, when clinical findings are insufficient to confidently diagnose the etiology of an infection, or in those situations in which the reaction is severe or has not responded to routine therapy, conjunctival scrapings for microscopic examination and cultures are indicated. These should also be performed in cases of neonatal conjunctivitis, hyperacute conjunctivitis, and chronic recalcitrant conjunctivitis.



    • Conjunctival cultures should be taken prior to the use of topical anesthetics, because these agents and their preservatives will reduce the recovery of certain bacteria. Cultures are taken by moistening a sterile alginate or dacron (not cotton) swab with sterile saline and wiping the lid margin or conjunctival cul-de-sac. The culture medium is then inoculated directly with the swab tip. Inoculation of solid media can be made in the shape of the letter R for the right lid and L for the left lid margin. On the same plate, a conjunctival culture may be inoculated at a different site using a zigzag pattern. In this way, the site of culture may be distinguished by the pattern of growth on the plate. After inoculating solid media, the tip of the applicator may be broken off and dropped into a tube of liquid culture medium (e.g., thioglycollate broth).


    • For bacterial isolation and identification, the most widely used and generally available media are blood agar and chocolate agar. Meat broth has a significantly higher growth rate for most common organisms but must be secondarily plated for identification. Chocolate agar is well suited for growth of any organism that can be isolated on blood agar and has the added advantage of isolating Haemophilus, the fastidious Neisseria organisms, and fungi. Thayer-Martin medium is a chocolate agar medium containing vancomycin, colistimethate, and nystatin and is of use in culture and isolation of gonococcus. Thioglycolate medium is a commonly used medium in cultivating aerobic and anaerobic organisms from ocular infection. Liquid Sabouraud medium may be useful in isolating fungal organisms when solid agar medium has failed. Table 5.3 summarizes the culture media of use in specific ocular infectious states. Cultures for B. henselae (catscratch disease) are difficult. Diagnosis is usually based on polymerase chain reaction (PCR) testing on local tissue biopsy and serology.


    • Scrapings for microscopic examination are made after cultures have been taken. Local anesthetic is instilled. A platinum spatula is flamed and allowed to cool to room temperature. The spatula can then be used to gently scrape the involved conjunctival surface, and the material obtained can be spread in a thin layer on a precleaned glass slide. If possible, two or three such slides are made and stained for microscopic examination (Table 5.4). Because scrapings

      are only about 70% reliable and may be traumatic to the patient, cultures take priority, and in appropriate situations, scrapings are omitted.








      TABLE 5.3 Culture Media






























































      General media Bacterial Fungal Parasitic Viral
      Blood agar plate Good recovery (37°C) Good recovery (room temperature)    
      Chocolate agar plate Especially Haemophilus, Neisseria, fungus      
      Sabouraud   Good recovery (broth or agar)    
      Chopped-meat broth Good recovery (37°C) Good recovery    
      Thioglycolate broth Microaerophilic species      
      Special media        
      (Lowenstein-Jensen, Thayer-Martin) Mycobacteria, Neisseria      
      Page medium to Escherichia coli plates     Good for Acanthamoeba  
      Viral carrier medium (minimal essential medium, Hank balanced salt solution) to human cell tissue culture       Good for herpes simplex, herpes zoster, adenovirus, pox








      TABLE 5.4 Cytologic Features of Conjunctivitis








































































      Cell Bacterial Viral Allergic TRIC
      Polymorphonuclear
      Neutrophil + + (Early) +
      Basoeosinophil (occasional) +  
      Mononuclear        
        Lymphocyte + +
        Plasma cell +
      Multinuclear +
      Inclusion        
        Cytoplasm + (Pox) +
        Nucleus + (Herpes)
      Organism +
      TRIC, trachoma-inclusion conjunctivitis (group); +, present; -, absent.


    • Stains most useful for identifying organisms and inflammatory cell type are the Gram or acridine orange. The Hansel stain is also a useful technique for rapid identification of any eosinophilic response. The Giemsa and Wright stains are most useful in revealing the condition and character of epithelial cells and inflammatory cells. The Giemsa stain is most effective in showing the presence or absence of viral cytoplasmic or intranuclear inclusion bodies and outlining the morphology of bacteria. The Gram stain is useful in revealing whether an organism is Gram positive or negative. It also provides some information about the morphology of the organism. For mycobacteria acid fast, lectin, and Gram stain, for fungi and acanthamoeba calcofluor white, and acridine orange are most useful. These organisms very rarely colonize the lids or conjunctiva.


    • The cytologic features of each type of conjunctivitis are helpful in diagnosis. As a rule, a polymorphonuclear leukocyte response occurs with bacterial conjunctivitis (with the exception of diplobacillus). Acute Stevens-Johnson syndrome may produce a polymorphonuclear response, as will the early stages of a viral infection. A mixed outpouring of polymorphonuclear leukocytes and lymphocytes is commonly noted with adult and neonatal inclusion conjunctivitis. Such a mixed response, with the added presence of plasma cells and macrophages (Leber cells), is almost diagnostic of trachoma. Chemical conjunctivitis can also produce a polymorphonuclear response. A predominantly lymphocytic response is most commonly seen in viral infections but can also be seen in drug-induced toxic follicular conjunctivitis. Numerous eosinophils are indicative of vernal conjunctivitis or allergic conjunctivitis. The appearance of eosinophils and polymorphonuclear leukocytes in conjunction with a hyperacute conjunctivitis may be indicative of early erythema multiforme, particularly if associated with systemic symptoms. Basophils, rarely seen in conjunctival scrapings, are equivalent in interpretation to eosinophilic reaction. Epithelial cells may demonstrate cytoplasmic inclusions that, if basophilic, suggest inclusion conjunctivitis and, if eosinophilic, suggest pox virus. Pink intranuclear inclusions on Giemsa stain are diagnostic of herpesvirus infection (either simplex or zoster). Multinucleate giant cells are suggestive of a viral disorder.


    • When organisms are identified, Gram-positive cocci in pairs or chains may indicate S. pyogenes. The Gram-negative diplococci, appearing within polymorphonuclear leukocytes and having the “coffee bean” shape, indicate Neisseria
      sp. Large Gram-negative diplobacilli characterize Moraxella sp. H. influenzae is a pleomorphic organism variably appearing as Gram-negative coccobacillus or slender rods. Gram-negative rods may also be noted but are difficult to differentiate as to species. Candida may appear hyphate on scrapings but are round organisms on culture.


  • Treatment of bacterial conjunctivitis and blepharitis (see also Chapter 3, Section I.1).



    • Acute mucopurulent conjunctivitis



      • Topical antibiotic therapy. Acute mucopurulent conjunctivitis will typically respond to topical antimicrobial therapy in solution or ointment form. If treatment is based on clinical diagnosis alone, topical antibiotics should be broad spectrum (i.e., anti- Staphylococcus sp, Streptococcus sp, and anti-Gram-negative organisms such as Moraxella, Serratia, Haemophilus, and Pseudomonas). Erythromycin or bacitracin ointment or sodium sulfacetamide 10% to 15% solution or ointment effectively covers only the more common Gram-positive infections. About 50% of staphylococci are resistant to the sulfonamides and erythromycin. There has been a significant increase in resistance to ciprofloxacin and cefazolin. Neomycin–polymyxin–bacitracin (Neosporin, Ocutricin, AK-Spore) is a very effective broad-spectrum antimicrobial (Gram-positive and -negative organisms are covered), but there is a 6% to 8% allergic sensitivity to neomycin. Polymyxin B–bacitracin (Polysporin, AK Poly-Bac) ointment and polymyxin B–trimethoprim drop (Polytrim) have excellent broad-spectrum coverage. Gentamicin (generics) and tobramycin (Tobrex), drops or ointment, are very good broad-spectrum agents but are usually reserved for suspected Gram-negative organisms. They are poorly effective against Streptococcus sp, and there is increasing incidence of resistance to Staphylococcus sp. The quinolones, ciprofloxacin (Ciloxan), ofloxacin (Ocuflox), levofloxacin (Quixin), gatifloxacin (Zymar), moxifloxacin (Vigamox), and norfloxacin (Chibroxin), have very broad and potent Gram-positive and -negative antibacterial activity with low, but unfortunately increasing, Gram-positive and -negative rates of bacterial resistance, especially for ciprofloxacin. Because of this and their potency, the quinolones should probably be reserved for more serious infections. Gram-negative coccobacilli are probably Haemophilus and should be treated with Polytrim as well as systemically (see below). Dosing schedules for all medicines are qid for 7 to 10 days, unless otherwise indicated.


      • Systemic therapy. For particularly acute staphylococcal blepharitis, oral dicloxacillin, or if penicillin allergy exists, erythromycin or azithromycin, are very effective adjuncts (see Appendix B). Methicillin-resistant staphylococci (MRSA) organisms are effectively treated with appropriate topical therapy, such as q2h to qid moxifloxacin or vancomycin along with p.o. doxy- or minocycline 100 mg p.o. bid for 10–14 days. Blepharokeratoconjunctivitis in children is not uncommon. Oral erythromycin for 1 to 12 months as needed and topical antibiotic therapy is an effective treatment. Recurrences are common and may be managed with low-dose steroid therapy such as fluoromethalone FML.


      • Local measures are of great value in treatment for both acute and chronic blepharitis. Warm wet compresses improve circulation, mobilize meibomian secretions, and help cleanse crusting deposits of the lashes. Thick or inspissated lid secretions may require the physician to express the lids between cotton-tipped applicators after topical anesthesia, followed by daily lid margin scrubs with commercial cleansing pads (Eye Scrub, Lid Wipes SPF) or daily baby shampoo scrubs (using fingertips) performed by the patient in the shower or at the sink. Seborrheic blepharitis is often improved by use of dandruff shampoo to the scalp and eyebrows. Daily application of steroid ointment such as fluoromethalone 0.1% ointment to lid margins for 2 to 3 weeks often controls the pronounced lid inflammation.


    • Hyperacute bacterial conjunctivitis (acute purulent conjunctivitis) is a more serious situation and demands more vigorous therapy. After the patient is
      examined and the necessary cultures and scrapings are obtained, it is important to institute treatment prior to obtaining the culture results.



      • Systemic therapy is indicated for Neisseria gonorrhoeae, N. meningitidis, and H. influenzae and is far more critical than topical therapy. Because more than 20% of N. gonorrhoeae cases are resistant, penicillin and tetracycline are no longer adequate as first-line treatment. If there is no corneal ulceration, recommended therapy that covers antimicrobial-resistant strains is ceftriaxone 1 g i.m. × 1, or for penicillin-allergic patients, spectinomycin 2 g i.m. × 1 or a fluoroquinolone such as moxifloxacin 400 mg p.o. qd × 5 d. If there is corneal ulceration, the patient should be admitted and treated with ceftriaxone 1 gm i.v. q12h × 3 days. For penicillin-allergic patients, treat with spectinomycin 2 g/d × 3 days or a quinolone such as moxifloxacin or gatifloxacin 400 mg p.o. qd × 7 to 10 days. All of the above regimens should be accompanied by frequent, copious sterile saline irrigation to remove debris and topical bacitracin or gentamicin ointment qid. Systemic therapy is followed by a 1-week course of either doxy- or minocycline 100 mg p.o. bid or erythromycin 250 to 500 mg p.o. qid. An alternative combination is ceftriaxone 1 g or 50 mg per kg i.v. once on an outpatient basis, followed by a week of doxycycline or erythromycin p.o. Doses are adjusted per Appendix B, in consultation with a pediatric or infectious disease consultant. For patients who may only be treated with oral medication, moxifloxacin, levofloxacin, or other quinolone, and cefaclor with probenecid are recommended (see Appendix B).


      • Prophylactic therapy for intimate contacts of N. gonorrhoeae patients is 1 g of ceftriaxone i.v. once or, for N. meningitidis, rifampin 600 mg p.o. q12h for 4 days. Isolation of H. influenzae in children warrants therapy with ampicillin 100 mg to 200 mg/kg i.m. or i.v. for 7 to 10 days or 50 mg to 100 mg/kg q6h to q8h p.o. for 10 to 14 days; neonates receive 50 mg to 200 mg/kg q12h i.m. or i.v. for 10 days (see Appendix B). Adult dosage is 2 g to 4 g p.o., i.m., or i.v. q6h to q8h for 10 to 14 days. If the Haemophilus strain is ampicillin resistant or the patient is penicillin allergic, a quinolone (e.g., levofloxacin, gatifloxacin, moxifloxacin), in the dosages described in Appendix B, is given for 10 to 14 days. The quinolones should not be used in neonates or children without consultation with a pediatrician or infectious disease consult.


      • Topical bacitracin or erythromycin ointment is instilled every 2 hours for the first 2 to 3 days for N. meningitidis, Streptococcus sp, C. diphtheriae, and N. gonorrhoeae in the neonate, child, or adult, and then five times daily for 7 days. Haemophilus or Moraxella infections are treated with topical quinolones, such as moxifloxacin, ofloxacin, or gentamicin, or tobramycin in the same dosage schedule as that for Neisseria. Frequent irrigation with sterile saline is very therapeutic in washing away infected debris.


    • Chronic conjunctivitis and blepharitis (see Sections III.B, earlier, and VII.I, as well as Chapter 3 for anterior and posterior blepharitis review) are especially common in patients with acne rosacea. It is rarely cultured, and then only if there is no response to standard treatment, and is then retreated in accordance with the sensitivities obtained after the pathogen is cultured.



      • Recalcitrant blepharitis, meibomitis, or infectious eczema dermatitis in association with chronic staphylococcal blepharoconjunctivitis requires not only topical antibiotic, bacitracin, or erythromycin bid, but also intensive hygiene of the lid margins. This hygiene may be initiated in the office by expression of the lid meibomian glands (using topical anesthesia) with cotton-tipped applicators. Daily lid hygiene with 5-minute warm compresses and lid margin massage with Eye Scrub or baby shampoo by the patient using the lathered fingertips are important in completely eradicating the inflammation. Daily hand and face scrubs with pHisoHex soap for 2 to 3 weeks and then three to four times weekly will lower the facial germ count and reduce acneiform eruptions and styes.



      • Certain systemic antibiotics also inhibit lid inflammation by decreasing production and activation of cytokines, nitric oxide, and matrix metalloproteinases. Doxycycline or minocycline 100 mg p.o. qd with a meal not containing calcium (which inactivates these drugs), oxytetracycline 250 to 500 mg p.o. bid (less convenient) on an empty stomach, or erythromycin 250 mg p.o. bid for 12 to 24 weeks are all generally very effective at relieving symptoms of dryness, blurring, itching, and photosensitivity and reducing inflammation and rosacea.


      • Metronidazole 1% gel (Metro Gel) bid to the facial skin and lid margins for 9 to 12 weeks is effective adjunctive rosacea therapy. Repeat all above as necessary.


      • Steroids. The inflammatory and vascular aspects of the lids and keratitis are extremely sensitive to low doses of topical steroid. Steroids must be used with caution, however, because there is a tendency for ulceration that may perforate. It is probably best to limit any steroid treatment to lotoprednol 0.2% or fluoromethalone 0.1% qd to bid.


      • Picrolimus (Elidel) cream or tacrolimus (Protopic) 0.03% ointment to the lids and periorbital tissues bid is effective in atopic dermatitis/blepharitis such as in excema.


    • Corneal marginal infiltrates and ulcerations that occur with chronic staphylococcal blepharoconjunctivitis respond to mild topical steroids with antibiotic cover, usually within 4 or 5 days. See IV.B.2.


    • Hordeolum, a tender, sometimes fluctuant lid margin nodule, is commonly seen with chronic blepharitis and may be multiple. Internal hordeola are inflammatory or infectious nodules in the meibomian glands, and external hordeola are the same but in the glands of Zeiss or lash follicles. Many will resolve within 2 weeks with warm compresses, lid hygiene, manual expression, and topical bacitracin tid or trimethoprim-polymyxin drops (Polytrim) qid. A nonresolving internal hordeolum becomes a chalazion, a chronic granulomatous nodule. Treatment is intralesional injection of 0.1 mL of triamcinolone 25 mg/mL to 40 mg/mL, or incision and drainage (vertical cut along the tarsal conjunctiva). As depigmentation may occur with dark-skinned patients, incision is probably the better choice for them. The steroid injection may be repeated if necessary. Meibomian gland carcinoma should be considered in the event of recurrence or nonresponse to therapy.


  • Catscratch fever (Parinaud ocular glandular syndrome, bartonellosis) responds well to doxycycline 100 mg p.o bid. Erythromycin 250 to 500 mg p.o. qid, or azithromycin (per ID consult) are effective and may be combined with adjuvent rifampin 300 mg p.o. bid for more severe infections. Duration of treatment is 2 to 4 weeks in immunocompetent patients and 4 months in immunocompromised patients


IV. Corneal infections and inflammation (keratitis and keratoconjunctivitis)



  • Superficial keratitis includes inflammatory lesions of the corneal epithelium and adjacent superficial stroma. Although some of the changes described in this section can be produced by noninflammatory conditions and therefore would more appropriately be considered keratopathy, they are considered here because of their diagnostic importance. The etiologies of this clinical condition include numerous infective, toxic, degenerative, and allergic conditions that can often be characterized by the morphology and distribution of the lesions produced. These conditions may occur with bacterial, viral, and fungal infections. Degenerative states resulting from dry eye, neurotrophic defects, or in association with systemic disease can also produce ulceration of the cornea. When accompanied by infiltration or significant ocular anterior chamber reaction, infection must be excluded or diagnosed and treated.



    • Morphology. The lesions include punctate epithelial erosions that are focal defects in the corneal epithelium, best visualized by rose bengal and fluorescein
      staining and slitlamp biomicroscopy. Punctate epithelial keratitis is characterized by focal inflammatory infiltration of the epithelium, resulting in minute opaque epithelial lesions observed in focal illumination or with the slitlamp. Although they may occur without staining, they often do stain with rose bengal or fluorescein because of associated punctate epithelial erosion. Punctate subepithelial infiltrates are nonstaining focal areas that occur as semiopaque spots in the superficial stroma.


    • Identification of the morphology and distribution of the lesions is greatly enhanced by the use of clinical vital stains, most notably rose bengal, lisamine green and fluorescein. Rose bengal and lissamine green stain dead or degenerating cells or cells without their normal mucin surface and are available as sterile paper strips (wet with saline, not proparacaine). Prior instillation of proparacaine 0.5% will relieve the smarting sensation produced by rose bengal, but tetracaine and cocaine should be avoided because they will often produce an artifactual rose bengal staining pattern. Rose bengal and lissamine green are also excellent stains for mucus and filaments. Fluorescein in combination with an anaesthetic solution (Fluress) or from a Fluri-strip wet with saline will stain epithelial defects or bared basement membrane and is also used when highlighting corneal filaments.


    • The distribution of the epithelial and subepithelial lesion is of diagnostic value. Figure 5.1 summarizes the six clinical patterns and their respective etiologies. Diffuse and nonspecific punctate epithelial erosions may occur with early bacterial or viral infections of many types. Breakdown of microcystic areas of epithelial edema can also produce this pattern, and such areas of edema will also demonstrate areas of negative staining in the fluorescein film corresponding to intact epithelial microcysts. Any toxic reaction to topical medications, chemicals, or aerosol sprays can produce this pattern. Mechanical trauma from a foreign body or eye rubbing must also be considered. The epithelial erosions secondary to molluscum contagiosum of the lids will occur in areas contiguous to the lesion. Inferior punctate epithelial erosions frequently result from staphylococcal blepharitis or blepharoconjunctivitis and are often accompanied by epithelial keratitis and subepithelial infiltrates. Trichiasis or incomplete lid closure (exposure keratopathy) can produce this distribution of erosion, and the pattern is also occasionally seen in dry eye patients. The interpalpebral distribution is typical of keratitis sicca, ultraviolet radiation exposure, chronic exposure, or incomplete blinking. Conjunctival staining usually will accompany the corneal lesion. Episodic recurrent erosions frequently will occur in the inferior area or interpalpebral area. The superior distribution of epithelial erosion is typical of superolimbic keratoconjunctivitis but can also be seen in vernal conjunctivitis and with trachoma. Corneal epithelial filaments (filamentary keratitis) consisting of coiled epithelial remnants and adherent mucous strands may be associated with any of these patterns, but most typically appear with superolimbic keratoconjunctivitis or keratoconjunctivitis sicca. Central lesions, with or without some peripheral punctate, suggest contact lens malfit or overwear, and linear lesions suggest a foreign body on the lid rubbing the cornea.


    • The etiology of punctate epithelial erosion is often local desiccation. Instability of the tear film results in focal dry spots and epithelial breakdown. Epithelial membrane damage from detergent chemicals, liquid solvents, quaternary amines, and a variety of drugs also results in erosions. Superficial viral and chlamydial infections can produce focal erosions, as can the epithelial hypoxia of contact lens overwear. Punctate epithelial keratitis with minute focal opacities is typical of viral keratitis, especially that associated with epidemic keratoconjunctivitis of adenovirus, but may also be seen with staphylococcal and chlamydial infections. The infiltrates also occur with vaccinia, Reiter syndrome, and acne rosacea. The coarse, granular infiltrates of punctate epithelial keratitis are quite characteristic of Thygeson superficial punctate keratitis.


    • Nonstaining punctate subepithelial infiltrates in the superficial stroma are sometimes seen after such entities as adenoviral, herpes simplex, herpes zoster,
      Epstein-Barr viral, vaccinial, chlamydial, Reiter, Lyme disease, and rosacea keratitis. Staphylococcal infection must be considered when this pattern appears in a marginal infiltrate distribution. Inferior peripheral limbal infiltrates can accompany acute H. influenzae conjunctivitis.






      Figure 5.1. Staining patterns of the cornea and conjunctiva in various disease states. TRIC, trachoma-inclusion conjunctivitis.


  • Bacterial corneal ulcers. Risk factors include contact lens wear, abnormal corneal surface, poor immune defense, trauma, topical steroids, and herpes.



    • Central ulcer. Predominant causes of central bacterial keratitis are Staphylococcus (e.g., S. aureus and S. epidermidis), Streptococcus (e.g., S. pneumococcus and groups A–G Streptococcus), other Gram-positive organisms (e.g., Bacillus and Propionibacterium sp), the Gram-negative organisms Haemophilus, Pseudomonas, and Moraxella, and other Enterobacteriaceae (e.g., Proteus, Serratia,
      E. coli, and Klebsiella
      ). Mycobacterium chelonae keratitis may follow laser-assisted in situ keratomileusis (LASIK) surgery. Gram-negative diplococci are an uncommon cause of corneal ulceration except in inadequately treated cases of hyperacute gonococcal conjunctivitis. Infection of the cornea usually tends to occur after injury to the epithelium or in compromised hosts, except for Neisseria and Corynebacterium, which may invade intact epithelium. Stromal infiltration in an area of an epithelial defect with surrounding edema and folds associated with endothelial fibrin plaques or anterior chamber reaction is usually indicative of microbial infection. Staphylococcal ulcers are often more localized, whereas pneumococcus may produce a shaggy undermined edge of an ulcer that is associated with a hypopyon. A destructive keratitis with rapid necrosis and adherent mucopurulent discharge is highly suggestive of Pseudomonas, Streptococcus, or anaerobic infection. Other uncommon causes are Nocardia and non–spore-forming anaerobes. Infectious crystalline keratopathy is an indolent, noninflammatory branching crystalline growth commonly associated with Streptococcus viridans, but also reported with Peptostreptococcus sp, S. epidermidis, H. influenzae, and two fungal species. There is also often a history of local ocular trauma, contact lens use, steroid use, and/or chronic antibiotic administration. Response to antibiotic therapy is very slow and may fail. Surgical intervention with neodymium:yttrium, aluminum, garnet (Nd:YAG) laser disruption (e.g., 3.2 mJ × 30) creates diffuse haze of the protective glycocalyx matrix within the intrastromal crystals, making the bacteria drug-susceptible. This should be considered before more extensive surgical steps are taken.


    • Marginal ulcers. The corneal limbus contains many antigen-presenting cells that mobilize T-lymphocytes to produce immune peripheral corneal infiltrates with or without ulceration. These usually sterile superficial white infiltrates are a hypersensitivity reaction seen most commonly with staphylococcal blepharoconjunctivitis but may also be seen with contact lens wear, trauma, and endopthalmitis. They are located 1 mm inside the limbus leaving a clear zone to the limbus. The ulceration must be distinguished from the Mooren ulcer and the peripheral ulceration seen with collagen vascular diseases such as rheumatoid arthritis. Moraxella sp has also been described as producing ulcers that extend to the limbus, especially inferiorly. Treatment is topical antibiotic with or without mild steroid for 7 to 10 days.


    • Laboratory tests similar to those for hyperacute conjunctivitis (see Section III.C) apply also to bacterial corneal disease.



      • Cultures are performed after instillation of topical proparacaine 0.5% (tetracaine, benoxinate, and cocaine are more likely to interfere with recovery of the organisms) and should obtain as much material as feasible, particularly from the deeper areas and the margin of the ulcer, using a sterile broth or saline-moistened calcium alginate or dacron–rayon swab. Organism recovery is much higher when alginate or Dacron swabs are used rather than cotton swabs or spatulas. Cultures are done on meat broth, blood agar plates (at room temperature and 38°C), chocolate agar, thioglycolate broth, and Sabouraud agar-broth (fungus), and Page’s medium (Acanthamoeba), if suspected. Scrapings taken from a nonnecrotic area may be examined microscopically with Gram and Giemsa stains. Because 30% to 40% will be negative even if infection is present, these scrapings may be judiciously omitted.


      • Corneal biopsy is often diagnostic in cases that progress despite seemingly adequate treatment; even if an organism has been identified, another may have been missed. In the minor operating room or at the slitlamp, after local anesthesia (drops or xylocaine block), a 2 to 3 mm sterile disposable dermatologic trephine is advanced to partial depth into the anterior corneal stroma, taking both clinically infected and adjacent clear cornea. The base is then undermined with a surgical blade to complete the lamellar keratectomy.


    • Treatment of central bacterial ulcers is based on clinical impression and results, if any, of the scraping. Coverage should be broad, intensive, and
      amenable to change when final culture and sensitivity reports are available. Contact lens wearers with central corneal ulcers should particularly be covered for Pseudomonas (q1h fortified tobramycin, netilmicin, and/or a quinolone [moxifloxacin, levofloxacin] for broader-spectrum cover). Antibiotic treatment of infectious corneal ulcers must be aggressive using fortified solutions (made up by compounding pharmacists), and patients should be kept under close observation to prevent serious scarring or frank perforation. Initial antibiotic therapy may be guided by the results of the Gram stain of the corneal scraping, but broad-spectrum therapy should be used (see Tables 5.5, 5.6, and 5.7 and Appendix B for detailed lists of drug indications, dosage, and routes of administration).








      TABLE 5.5 Initial Topical Antibiotic Therapy of Bacterial Keratitis Based on Gram-stain Findingsa
































      Bacterial type Drugs of choice (fortified) Alternative drugs (fortified and nonfortified)
      Gram-positive cocci Cefazolin, 100 mg/mL,
      Moxifloxacin,b,c
      Gatifloxacin,b,c
      Vancomycin, 25 mg/mL (MRSA)a
      Bacitracin, 10,000 U/mL
      Ciprofloxacin,b,c ofloxacin,b,c or levofloxacinb,c
      Gram-positive bacilli (filaments) Penicillin G, 100,000 U/mL Vancomycin, 25–50 mg/mL
      Bacitracin, 10,000 U/mL
      Gram-positive rods Tobramycin, 14 mg/mL Gentamicin, 14 mg/mL
      Gram-negative cocci Ceftriaxone or ceftazidime, 50 mg/mLd
      Moxifloxacinb,c,d5 mg/ mL
      Levofloxacin,b,c,dGatifloxacin,b,c Ofloxacin,b,c,dor Ciprofloxacinb,c,d3 or 5 mg/mL
      Gram-negative bacilli Moxifloxacinb,c,dplus
      Tobramycin, 14 mg/mL or
      Ceftazidime, 50 mg/mLdor
      Ticarcillin, 6 mg/mL
      Gentamicin, 14 mg/mL or Amikacin, 10 mg/mL (replace tobramycin)
      Ciprofloxacin,b,c ofloxacin,b,c gatifloxacin, or levofloxacinb,c in place of moxifloxacin
      No organisms seen, but bacteria suspectede Cefazolin, 100 mg/mL, plus tobramycin 14 mg/mL or moxifloxacinb,c,d Gentamicin, 14 mg/mL, or amikacin, 10 mg/mL, plus vancomycin, 25 mg/mL, or bacitracin, 10,000 U/mL (MRSA suspected)a or other quinolone
      aSee also Table 5.7 for dosage and preparation of fortified drops and subconjunctival doses, and Appendix B for expanded drug dosage list and organism-susceptibility guide. MRSA = methicillin-resistant Staph. aureus Subconjunctival and systemic therapy use is based on extent of disease (see Table 5.7).
      bDrops available as commercial ophthalmic preparations.
      cNot available in fortified form. Commercial strength only. Systemic therapy should be used in addition to local treatment for Neisseria or Hemophilus infection (see Section III.D.2).
      dNot U.S. Food and Drug Administration approved for topical therapy of Neisseria.
      eSmall to medium peripheral infiltrates may be treated with a quinolone (moxifloxacin, ofloxacin, levofloxacin, ciprofloxacin).



      • Gram-positive cocci. In mild to moderate infections, frequent topical therapy alone may be used, but it may be advisable to give subconjunctival therapy as well in severe infections, or apply a collagen contact lens soaked 10 minutes in fortified antibiotic solution (see Section IV.B.6).









        TABLE 5.6 Subsequent Therapy for Most Common Culture-Identified Bacterial Ulcersa




















        Organisms Topical Subconjunctivala
        Pseudomonas Tobramycin, 14 mg/mL, or amikacin, 10 mg/mL, and moxifloxacin Tobramycin, 40 mg (1 mL), amikacin, 25 mg, or ticarcillin, 100 mg
        Staphylococcus Cefazolin, 100 mg/mL, vancomycin,c 25–50 mg/mL, or bacitracin, 10,000 U/mL and/or a quinolone Cefazolin, 100 mg, oxacillin, 100 mg, or vancomycin, 25 mg (MRSA)
        Proteus, Enterobacter, Escherichia coli, Klebsiella, Acinetobacter Tobramycin, 14 mg/mL, gentamicin, 14 mg/mL, amikacin, 10 mg/mL, or ceftriaxone, 50 mg/mL, and/or a quinolone Tobramycin amikacin, 25 mg, or carbenicillin, 100 mg
        aSee Appendix B for parenteral use of these and other drugs and organism-susceptibility guide. See Table 5.7 for method of preparation of fortified drops and subconjunctival doses.
        bUncooperative patient or pending of actual scleral involvement. Add systemic antibiotics.
        cMRSA = Methicillin-resistant organisms.



        • Coupled fortified cephalosporin–aminoglycoside therapy is common. Topical cefazolin solution, 100 mg/mL, should be used q1min for five doses to achieve high stromal levels quickly and then q1h 24 hours per day or 16 times per day with a polymyxin–bacitracin ointment HS depending on severity of disease. Tobramycin is often effective against Staphylococcus, but poorly effective against pneumococcus or other Streptococcus. Fortified drops of one of these aminoglycosides are used in the same regimen as cefazolin to cover any Gram-negative organisms that may be revealed only by culture. Vancomycin (14 to 25 mg/mL) or bacitracin (10,000 U/mL) is effective in Gram-positive coccal and bacillus infections, and especially methicillin-resistant Staphylococcus, where cephalosporins would fail. As Streptococciare variably sensitive to second generation quinolones such as cipro and oxyfloxacin, cell wall-active agents such as bacitracin, cefazolin, or vancomycin are preferable. Drops are tapered over a 1- to 2-week period to qid for 3 weeks more as indicated. Other Gram-positive coverage is with cefuroxime, cefazolin or neomycin while Gram-negative cover is achieved with gentamicin, amikacin, ceftazidime, levofloxacin or ofloxacin. For methicillin-resistant organisms, vancomycin (25 mg/mL) is the drug of choice, with linezolid (25 mg/mL) as an excellent alternative in cases of vancomycin-resistance. Intraocular penetration of linezolid 600 mg p.o. is in excess of the MC90 of Gram-positive bacteria, including vancomycin-resistant enterococcus, MRSA, and streptococcal species, after 2 doses 12 hours apart. Trimethoprim-sulfamethosazole (Bactrim DS) 1 p.o. bid × 10 to 21 days with drops (Polytrim) q1h by day to qid is also effective in MRSA infections.


        • Single-agent broad-spectrum drops of the quinolones may be used alone (moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin–although the latter two have an increasing incidence of resistance). More severe ulcers should probably be treated at least initially with fortified double agents such as cephazolin and tobramycin (Section IV.B), but a quinolone may be substituted when the situation is under control and organism(s) known, as they are highly effective an commercially available. Organisms covered are similar to those for cefazolin or vancomycin and an aminoglycoside and include the microbes listed in Section III.B.1.









          TABLE 5.7 Preparation of Antibiotics for Fortified Topical and Subconjunctival use














































































































































          Antibiotic (i.m. or i.v. Formulation) Commercial Solution Fortified Topical Drops Subconjunctival
          Diluenta (mL) Added to 1.0 mL Commercial Solution Final Concentration Shelf Life (4°C)b (d) Diluent (mL) Volume of Added to 1.0 mL Commercial Solution Final Concentration Final Dose
          Amikacin 100 mg/1 mL 9.0 10 mg/mL 30 1.0 50 mg/mL 25 mg–50 mg
          Bacitracin 50,000 U/5 mL 10,000 U/mL 7 10,000 U/mL 5000 U
          Carbenicillin 1.0 g/10 mL 24.0 4 mg/mL 3 100 mg/mL 100 mg
          Cefamandole 1.0 g/7.5 mL 133 mg/mL 4 0.3 100 mg/mL 100 mg
          Cefazolin 1.0 g/10 mL 2.0 33 mg/mL 10
          Cefazolin 1.0 g/7.5 mL 133 mg/mL 10 0.3 100 mg/mL 100 mg
          Ceftriaxone 1.0 g/7.5 mL 133 mg/mL 10 0.3 100 mg/mL 100 mg
          Chloramphenicol 1.0 g/10 mL 19.0 5 mg/mL 7 100 mg/mL 100 mg
          Gentamicin 80 mg/2 mL 1.8 14 mg/mL 30 40 mg/mL 20 mg–40 mg
          Penicillin G potassium 1 million U/mL 9.0 100,000 U/mL 7 1 million U/mL 1 million U
          Polymyxin B 500,000 U/20–50 mL 10–25,000 U/mL 3 10,000 U/mL 10,000 U/mL
          Ticarcillin 1.0 g/10 mL 16.0 6 mg/mL 14
          Tobramycin 80 mg/2 mL 1.8 14 mg/mL 30 40 mg/mL 20 mg–40 mg
          Vancomycin 500 mg/10 mL 1.0 25 mg/mL 14 50 mg/mL 25 mg
          i.m., intramuscular; i.v., intravenous.
          aWith the exception of carbenicillin and vancomycin (sterile water for injection only) and bacitracin (normal saline for injection only), diluent may be sterile water or saline for injection (USP), or sterile artificial tears using the original tears bottle to administer the reconstituted drug solution.
          b Freezing extends expiration time to 12 weeks for aminoglycosides, cephalosporins, and vancomycin; 4 weeks for ticarcillin.



        • Subconjunctival therapy is usually used only in severe cases or for uncooperative or unreliable patients. Because a 10% cross-sensitivity between cephalosporins and penicillin has been reported in penicillin-allergic patients, it is usually safer to proceed with vancomycin therapy. Subconjunctival injections are painful and best preceded by topical anesthetic (or general anesthetic when treating children) and adequate postinjection analgesics.


      • Gram-negative cocci (N. meningitidis, N. gonorrhoeae) and Haemophilus require systemic and topical therapy and are discussed under hyperacute conjunctivitis (see Section III.C). Topical therapy should be q1h for 2 to 4 days with taper over 2 to 4 weeks.


      • Gram-positive rods. These uncommon agents of ocular infection usually respond to systemic penicillin (see Appendix B). Bacillus sp are susceptible to moderate doses of penicillin; clostridial organisms require higher doses. Bacillus cereus infections may be extremely hard to treat, even using tobramycin, moxifloxacin, ofloxacin, norfloxacin, ciprofloxacin, or clindamycin. Topical drops and subconjunctival injections are used q1h. Tetracycline topically (compounding pharmacist) and orally is a useful adjunctive.


      • Gram-negative rods



        • Topical therapy initially should be fortified tobramycin ophthalmic solution q1min for five doses, then q1h for 3 to 6 days before starting slow taper. Important adjunctive therapy is topical ticarcillin 6 mg/mL, or carbenicillin 4 mg/mL, q1h. Treat Pseudomonas at least 1 month, or rebound infection may occur. Aminoglycoside-resistant strains are increasing. If Pseudomonas is gentamicin-resistant, a quinolone drop should be coupled with ticarcillin or carbenicillin, as above. If the strain is quinolone-resistant, amikacin is often effective.


        • Subconjunctival therapy, if used, should include tobramycin or amikacin 40 mg and carbenicillin 100 mg, each injected in a different area of the conjunctiva.


      • Anaerobic Gram-positive filaments (Actinomyces, Nocardia [formerly Streptothrix]) are sensitive to penicillins and tetracyclines.


      • Mycobacterium chelonae are acid-fast organisms culturable on Lownestein-Jensen medium. Ulcers are treated with a combination of oral and topical clarithromycin (10 mg/mL) or moxifloxacin or gatifloxacin. The drops are hourly around the clock to start with, then tapered over weeks. Oral doxycycline 100 mg bid is additive therapeutically for 4 to 6 weeks.


      • When no organisms are identified but bacterial etiology is strongly suspected on clinical grounds:



        • Topical therapy should be with fortified cefazolin q1min for five doses, then coupled with tobramycin 14 mg/mL q1h, at least 16 doses/day for 3 to 6 days before taper over 4 to 6 weeks. Use vancomycin in place of cepahzolin in severe cases and suspected methicillin-resistant or penicillin-allergic patients. See Gram-positive cocci above.


        • Subconjunctival therapy, if used, should be cefazolin 100 mg, plus tobramycin 40 mg, until culture results are available. A fortified antibiotic-soaked collagen lens (see Section IV.B.6) may also be effective adjunctively.


      • Systemic antibiotics are used if there is scleral extension of the infection or a threatened perforation. Levofloxacin 500 mg p.o. q24h or ofloxacin 200 mg to 400 mg p.o. q12h for 7 days both have excellent aqueous and vitreous penetration after oral dosing. A cephalosporin or vancomycin and an aminoglycoside may also be used p.o. or i.v., with doses given as in Appendix B. In cases of vancomycin resistance, which is an emerging problem, linezolid 600 mg i.v. or p.o. q12h is indicated. Optic neuropathy may be a complication of this route. Tables 5.5, 5.6, 5.7, and Appendix B summarize the recommended therapy. Therapy may be refined when culture and sensitivities return.


      • The antibiotic regimen is altered, if necessary, when final culture and sensitivity information is available. Fortified vancomycin and bacitracin are
        used if MRSA are recovered. Most strains are also sensitive to linezolid, trimethoprim SMX, doxy- or minocycline but should be tested for sensitivity. Many MRSA strains are resistant to levofloxacin (and other quinolones) and erythromycin, as well as penicillins and cephalosporins. In the event that a suspected Gram-negative coccus infection was initially treated with penicillin and the subsequent culture results disclose Acinetobacter sp, penicillin should be discontinued because these organisms are often not sensitive to penicillin.


    • Other treatment modalities



      • Dilation. Long-acting cycloplegics such as atropine 1% or scopolamine 0.25% should be used if significant anterior chamber reaction is present. Initial instillation is usually required at least three times a day. If significant synechiae are forming at the pupillary margin, one or two doses of topical 2.5% phenylephrine are often indicated to ensure mobility of the pupil.


      • Corticosteroid use in treatment of infectious corneal ulcers is less controversial than in past years. It is probably unwise to use steroids until at least 24 to 48 hours of antibacterial treatment has been completed, or until the etiologic agent has been identified and shown to be sensitive to the antibiotics being used. Corticosteroid use is contraindicated if Pseudomonas or fungus are at all suspected. Both of these organism types tend to persist in low numbers for weeks after apparent clinical resolution. Low-dose topical corticosteroids (e.g., prednisolone 0.12% rimexolone or lotoprednol qid) have a place in limiting the inflammatory reaction once the clinician is satisfied that the antibiotic treatment is effective.


    • Collagen shields (Surgilens, Bausch & Lomb) are contact lenses initially developed to enhance corneal epithelial healing after surgery, trauma, or dystrophic erosions and filaments, but are also used as effective high-dose drug delivery systems (the lenses are not FDA approved as drug delivery systems). The lenses come in two sizes and dissolve spontaneously over 24 to 72 hours. Soaking the lenses in antibiotics, such as tobramycin 40 mg solution for 10 minutes, results in a 30-fold increase in antibiotic penetration into the aqueous compared to subconjunctival injection or a regular therapeutic soft contact lens (TSCL) and q1h drops. The high level of drug may be maintained with q4h drops using the collagen shields.


    • Special pediatric considerations. Subconjunctival therapy is usually not feasible unless the child is under general anesthesia at the time of a corneal culture and scraping. Should systemic medication be considered necessary, it is best done with the consultation of a pediatrician or internist. See Appendix B for dosages and organism indications.


Jun 12, 2016 | Posted by in OPHTHALMOLOGY | Comments Off on Cornea and External Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access